Abstract
The T-type Ca++ channel is widely distributed. Its physiological roles have not been well established because of the lack of a selective T-channel blocker. By using the suction pipette method, the authors describe (7-[[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]methyl]-2-[(2- hydroxyethyl)amino]4-(1-methylethyl)-2,4,6-cycloheptatrien-1-one) or U-92032, which selectively blocks rested closed T-type Ca++ channels (T channel). After a 3-min exposure to external U-92032 (1 microM), a 50% resting block of the T channel was observed on the first step depolarization from -90 to -40 mV; subsequent stimulations at 0.1 Hz produced little further block. The L-type Ca++ current (L channel) was not affected. At 10 microM, U-92032 produced about 100% resting block of the T and 20% block of the L channels. Subsequent stimulations at 0.1 Hz increased the block of L channel to 56% at the sixth pulse, which indicated strong use dependence at negative potentials and low stimulation rates. Blockade of the T channel did not alter channel steady-state activation and inactivation or current inactivation time courses. By contrast, blockade of the L channel shifted the midpoint of its steady-state inactivation curve from -20.6 mV to -27.8 mV and accelerated its slow inactivation time course, from 171 +/- 16 msec to 79.8 +/- 9.3 msec. Moreover, the 90% recovery time from inactivation was increased from 0.12 to 60 sec. Because U-92032 is ionized at pH 7, its inability to affect the T channel gating property may suggest external drug binding sites.(ABSTRACT TRUNCATED AT 250 WORDS)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|